Sign Up Today and Learn More About Aera Therapeutics Stock
Invest in or calculate the value of your shares in Aera Therapeutics or other pre-IPO companies through EquityZen's platform.
Aera Therapeutics Stock (AEAT)
Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.
About Aera Therapeutics Stock
Founded
2021
Headquarters
Boston, MA, US
Industries
Data and Analytics, Science and Engineering, Health Care
Aera Therapeutics Press Mentions
Stay in the know about the latest news on Aera Therapeutics
Chutes & Ladders—BMS oncology head swings to Syndax
fiercebiotech • May 17, 2025
Aera Therapeutics Appoints Paul Conrad, Ph.D., MBA, as Chief Business and Financial Officer
citybiz • May 17, 2025
Paul Conrad joins Aeta Therapeutics as chief business and financial officer
thepharmaletter • May 16, 2025
Feng Zhang’s protein nanoparticle startup Aera Therapeutics turns to lipid nanoparticles to jumpstart its pipeline
endpts • May 04, 2025
Pnma2-based capsids and uses thereof
patents • Apr 02, 2025
Aera Therapeutics Management
Leadership team at Aera Therapeutics
Board Member
Akin Akinc
Board Member
Robert Nelsen
Join now and verify your accreditation status to gain access to:
- Aera Therapeutics Current Valuation
- Aera Therapeutics Stock Price
- Aera Therapeutics Management
- Available deals in Aera Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Aera Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Aera Therapeutics Revenue and Financials
- Aera Therapeutics Highlights
- Aera Therapeutics Business Model
- Aera Therapeutics Risk Factors
- Aera Therapeutics Research Report from SACRA Research
Trading Aera Therapeutics Stock
How to invest in Aera Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Aera Therapeutics through EquityZen funds. These investments are made available by existing Aera Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Aera Therapeutics stock?
Shareholders can sell their Aera Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
